Synalar is a topical medication formulated as a cream or ointment that contains a synthetic corticosteroid as its active ingredient. It is used to treat a variety of inflammatory skin conditions such as eczema, psoriasis, and allergic reactions. The medication works by suppressing the immune response in the skin to reduce redness, swelling, and itching. Its active steroid binds to intracellular glucocorticoid receptors and influences gene transcription to decrease the production of inflammatory cytokines. This action modulates the physiological pathways that cause vasodilation and cellular infiltration in the affected tissue. By reducing these processes the drug alleviates symptoms and promotes healing of the skin barrier. The overall effect provides both anti-inflammatory and immunosuppressive benefits for short-term management of dermatological disorders.

Synalar is a nonprescription antiinflammatory medication used to relieve mild to moderate pain and swelling. It belongs to the class of selective cyclooxygenase inhibitors that block the production of prostaglandins. By reducing prostaglandin levels the drug lowers inflammatory signaling in tissues and decreases nerve sensitivity to pain. This dual action also helps lower fever by acting on the hypothalamic thermoregulatory center. The medication is absorbed quickly after oral administration and exerts its effects systemically through circulation. Its pharmacological activity is intended to provide sustained antiinflammatory and analgesic relief without significant systemic toxicity.

Some users may experience mild skin irritation when applying Synalar. Dryness of the treated area can occur with regular use. Redness or a burning sensation may appear after application. Itching may develop in some individuals. The product can occasionally cause a temporary thinning of the skin surface. These effects are generally mild and reversible upon discontinuation.

Synalar is a topical corticosteroid used to treat certain skin conditions. It can cause mild skin irritation such as burning or itching at the application site. Some users report dryness or flaking of the skin after prolonged use. Less commonly, changes in skin pigmentation may occur, making the treated area lighter or darker. Occasional contact dermatitis may develop, leading to redness or swelling. Systemic side effects are rare but may include thinning of the skin with long-term high-dose use. Because side effects can vary, it is important for patients to follow application instructions carefully.